Circulating leptin in patients with chronic obstructive pulmonary disease

American Journal of Respiratory and Critical Care Medicine

Volumn 159, Issue 4 I, 1999, Pages 1215-1219

  Takabatake, Noriaki ^a   Nakamura, Hidenori ^a   Abe, Shuichi ^a   Hino, Toshihiko ^a   Saito, Hiroshi ^a   Yuki, Hideki ^a   Kato, Shuichi ^a   Tomoike, Hitonobu ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BODY FAT; BODY MASS; CACHEXIA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM;

EID: 0032960162     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.159.4.9806134     Document Type: Article

References (46)

1. Schols, A.M.W.J., P. B. Soeters, R. Mostert, W. H. M. Saris, and E. F. M. Wouters. 1991. Energy balance in chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 143:1248-1252.
2. Schols, A. M. W. J., P. B. Soeters, A. M. C. Dingemans, R. Mostert, P. J. Frantzen, and E. F. M. Wouters. 1993. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am. Rev. Respir. Dis. 147:1151-1156.
3. Wilson, D. O., R. M. Rogers, E. Wright, and N. R. Anthonisen. 1989. Body weight in chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 139;1435-1438.
4. Donahoe, M., R. M. Rogers, D. O. Wilson, and B. E. Pennock. 1989. Oxygen consumption of the respiratory muscles in normal and malnourished patients with chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 140:385-391.
5. Sridhar, M. K., R. Carter, M. E. J. Lean, and S. W. Banham. 1994. Resting energy expenditure and nutritional state of patients with increased oxygen cost of breathing due to emphysema, scoliosis and thoracoplasty. Thorax 49:781-785.
6. Hugli, O., Y. Schutz, and J. W. Fitting. 1995. The cost of breathing instable chronic obstructive pulmonary disease. Clin. Sci. 89:625-632.
7. Auwerx, J., and B. Staels. 1998. Leptin. Lancet 351:737-742.
8. Flier, J. S. 1997, Leptin expression and action: new experimental paradigms. Proc. Natl. Acad. Sci. U.S.A. 94:4242-4245.
9. Tartaglia, L. A. 1997. The leptin receptor. J. Biol. Chem. 272:6093-6096.
10. Maffei, M., J. Halaas, E. Ravussin, R. E. Pratley, G. H. Lee, Y. Zhang, H. Fei, S. Kim, R. Lallone, S. Ranganathan, P. A. Kern, and J. M. Friedman. 1995. Leptin levels in human and rodent: measurement of plasma leptin and oh RNA in obese and weight-reduced subjects. Nature Med. 1:1155-1161.
11. Considine, R. V., M. K. Sinha, M. L. Heiman, A. Kriauciunas, T. W. Stephens, M. R. Nyce, J. P. Ohannesian, C. C. Marco, L. J. McKee, T. L. Bauer, and J. F. Caro, 1996. Serum immunoreactive leptin concentrations in normal-weight and obese humans. N. Engl. J. Med. 334:292-295.
12. Merabet, E., S. Dagogo-Jack, D. W. Coyne, S. Klein, J. V. Santiago, S. P. Hmiel, and M. Landt. 1997. Increased plasma leptin concentration in end-stage renal disease. J. Clin. Endocrinol. Metab. 82:847-850.
13. Grunfeld, C., C. Zhao, J. Fuller, A. Pollock, A. Moser, J. Friedman, and K. R. Feingold. 1996. Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters: a role for leptin in the anorexia of infection. J. Clin. Invest. 97:2152-2157.
14. De Vos, P., R. Saladin, J. Auwerx, and B. Staels. 1995. Induction of ob gene expression by corticosteroids is accompanied by body weight loss and reduced food intake. J. Biol. Chem. 270:15958-15961.
15. Di Francia, M., D. Barbier, J. L. Mege, and J. Orehek. 1994. Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 150:1453-1455.
16. de Godoy, T., M. Donahoe, W. J. Calhoun, J. Mancino, and R. M. Rogers. 1996. Elevated TNF-α production by peripheral blood monocytes of weight-losing COPD patients. Am. J. Respir. Crit. Care Med. 153: 633-637.
17. Traccy, K. J., H. Wei, K. R. Manogue, Y. Fong, D. G. Hesse, H. T. Nguyen, G. C. Kuo, B. Beutler, R. S. Cotran, and A. Cerami. 1988. Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation. J. Exp. Med. 167:1211-1227.
18. Argiles, J. M., J. Lopez-Soriano, S. Busquets, and F. J. Lopez-Soriano. 1997. Journey from cachexia to obesity by TNF. FASEB J. 11:743-751.
19. Balkwill, F., R. Osborne, F. Burke, S. Naylor, D. Talbot, H. Durbin, J. Tavernier, and W. Fiers. 1987. Evidence for tumor necrosis factor/ cachectin production in cancer. Lancet 2:1229-1232.
20. Norman, D., J. S. Elborn, S. M. Cordon, R. J. Rayner, M. S. Wiseman, E. J. Hiller, and D. J. Shale. 1991. Plasma tumour necrosis factor-alpha in cystic fibrosis. Thorax 46:91-95.
21. Nozaki, N., S. Yamaguchi, M. Shirakabe, H. Nakamura, and H. Tomoike. 1997. Soluble tumor necrosis factor receptors are elevated in relation to severity of congestive heart failure. Jpn. Circ. J. 61:657 664.
22. Sarraf, P., R. C. Frederick, E. M. Turner, G. Ma, N. T. Jaskowiak, D. J. Rivet III, J. S. Flier, B. B. Lowell, D. L. Fraker, and H. R. Alexander. 1997. Multiple cytokines and acute inflammation raise mouse leptin levels: potential role in inflammatory anorexia. J. Exp. Med. 185:171-175.
23. Zumbach, M. S., M. W. J. Boehme, P. Wahl, W. Stremmel, R. Ziegler, and P. P. Nawroth. 1997. Tumor necrosis factor increases serum leptin levels in humans. J. Clin. Endocrinol. Metab. 82:4080-4082.
24. Diez-Ruiz, A., G. P. Tilz, R. Zangerle, G. Baier-Bitterlich, H. Wachter, and D. Fuchs. 1995. Soluble receptors for tumor necrosis factor in clinical laboratory diagnosis. Eur. J. Haematol. 54:1-8.
25. American Thoracic Society. 1987. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am. Rev. Respir. Dis. 136:225-243.
26. Maury, C. P. J., and A. M. Teppo. 1989. Tumor necrosis factor in the serum of patients with systemic lupus erythematosus. Arthritis Rheum. 32:146-150.
27. Nyström, F., B. Ekman, M. Österlund, T. Lindström, K. P. Öhman, and H. J. Arnqvist. 1997. Serum leptin concentrations in a normal population and in GH deficiency: negative correlation with testosterone in men and effects of GH treatment. Clin. Endocrinol. 47:191-198.
28. Lukaski, H. C., P. E. Johnson, W. W. Bolonchuk, und G. I. Lykken. 1985. Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am. J. Clin. Nutr. 41:810-817.
29. Quanjer, P. H., editor. 1983. Standardized lung function testing. Bull. Eur. Physiopathol. Respir. 19:7-44.
30. Ma, Z., R. L. Gingerich, J. V. Santiago, S. Klein, C. H. Smith, and M. Landt. 1996. Radioimmunoassay of leptin in human plasma. Clin. Chem. 42:942-946.
31. Hino, T., H. Nakamura, Y. Shibata, S. Abe, S. Kato, and H. Tomoike. 1997. Elevated levels of type II soluble tumor necrosis factor receptors in the bronchoalveolar lavage fluids of patients with sarcoidosis. Lung 175:187-193.
32. Grinspoon, S., T. Gulick, H. Askari, M. Landt, K. Lee, E. Anderson, Z. Ma, L. Vignati, R. Bowsher, D. Herzog, and A. Klibanski. 1996. Serum leptin levels in woman with anorexia nervosa. J. Clin. Endocrinol. Metab. 81:3861-3863.
33. Grunfeld, C., M. Pang, J. K. Shigenaga, P. Jensen, R. Lallone, J. Friedman, and K. R. Feingold. 1996. Serum leptin levels in the acquired immunodeficiency syndrome. J. Clin. Endocrinol. Metab. 81:4342-4346.
34. Scannell, G., K. Waxman, G. J. Kaml, G. Ioli, T. Gatanaga, R. Yamamoto, and G. A. Granger. 1993. Hypoxia induces a human macrophage cell line to release tumor necrosis factor-alpha and its soluble receptors in vitro. J. Surg. Res. 54:281-285.
35. Torre-Amione, G., S. Kapadia, J. Lee, J. B. Durand, R. D. Bies, J. B. Young, and D. L. Mann. 1995. Tumor necrosis factor-α and tumor necrosis factor receptors in the failing human heart. Circulation 93:704-711.
36. Nakamura, H., T. Hino, S. Kato, Y. Shibata, H. Takahashi, and H. Tomoike. 1996. Tumor necrosis factor receptor gene expression and shedding in human whole lung tissue and pulmonary epithelium. Eur. Respir. J. 9: 1643-1647.
37. Rich. E. A., J. R. Panuska, R. S. Wallis, C. B. Wolf, M. L. Leonard, and J. J. Ellner, 1989, Dyscoordinate expression of tumor necrosis factor-alpha by human blood monocytes and alveolar macrophages. Am. Rev. Respir. Dis. 139:1010-1016.
38. Lantz, M., U. Gullberg, E. Nilsson, and I. Olsson. 1990. Characterization in vitro of a human tumor necrosis factor-binding protein: a soluble form of a tumor necrosis factor receptor. J. Clin. Invest. 86:1396-1402.
39. Hjalmarsen, A., U. Aasebo, K. Birkeland, G. Sager, and R. Jorde. 1996. Impaired glucose tolerance in patients with chronic hypoxic pulmonary disease. Diabete Metabol. 22:37-42.
40. Semple, Pd'A., G. H. Beastall, W. S. Watson, and R. Hume. 1980. Serum testosterone depression associated with hypoxia in respiratory failure. Clin. Sci. 58:105-106.
41. Aasebo, U., A. Gyltnes, R. Bremnes, A. Aakvaag, and L. Slordal. 1993. Reversal of sexual impotence in male patients with chronic obstructive pulmonary disease and hypoxacmia with long-term oxygen therapy. J. Steroid Biochem. Mol. Biol. 46:799-803.
42. Gossney, R. 1987. Atrophy of Leydig cells in the testes of men with longstanding chronic bronchitis and emphysema. Thurax 42:615-619.
43. Semple, Pd'A., G. H. Beastall, W. S. Watson, and R. Heme. 1981. Hypothalamic-pituitary dysfunction in respiratory hypoxia. Thorax 36:605-609.
44. Pape, G. S., M. Friedman, L. E. Underwood, and D. R. Clemmons. 1991. The effect of growth hormone on weight gain and pulmonary function in patients with chronic obstructive lung disease. Chest 99:1495-1500.
45. Burdet, L., B. de Muralt, Y. Schulz, C. Pichard, and J. W. Fitting. 1997. Administration of growth hormone to underweight patients with chronic obstructive pulmonary disease: a prospective, randomized, controlled study. A m. J. Respir. Crit. Care. Med. 156:1800-1806.
46. Lord, G. M., G. Matarese, J. K. Howard, R, J. Baker, S. R. Bloom, and R. I. Lechler. 1998. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 394:897-901.